Skip to content
HORALID pack shot
Growth regulatorSL

HORALID

Regolatore di Crescita / Fungicida

Mepiquat chloride
210 g/L
Metconazole
30 g/LFRAC 3
Mode of actionFRAC 3

HORALID è un regolatore di crescita della colza e del lino da fibra, nonché un fungicida contro la cilindrosporiosi della colza. Formulato come concentrato solubile (SL), contiene 210 g/L di cloruro di mepiquat e 30 g/L di metconazolo. Il prodotto agisce inibendo la biosintesi delle gibberelline per ridurre la crescita e inibendo la biosintesi dell'ergosterolo per combattere le malattie fungine.

Key uses(3)

  • Regolatore di crescita
  • Cilindrosporiosi
  • Limitazione della crescita

Registered in FranceFrance

Approved uses

Registration, documents and approved uses for this market.

Approved
Registration no.2210328
Pack sizes5L

Label & safety data

Tap to open · use the download button to save a copy.

Approved uses

CropTargetsPHIBBCH
Colza80d14
Lino

Safety & hazard classification

Signal word

danger

Pictograms

  • GHS05 — Corrosives / Metal corrosion / Skin & eye damageCorrosives / Metal corrosion / Skin & eye damage
  • GHS07 — Irritants / Acute toxicity Cat 4 / Skin sensitiserIrritants / Acute toxicity Cat 4 / Skin sensitiser
  • GHS09 — Hazardous to the aquatic environmentHazardous to the aquatic environment

Hazard statements

  • H302Harmful if swallowed.
  • H317May cause an allergic skin reaction.
  • H318Causes serious eye damage.
  • H332Harmful if inhaled.
  • H410Very toxic to aquatic life with long lasting effects.
  • EUH401To avoid risks to human health and the environment, comply with the instructions for use.

Precautionary statements

  • P102Keep out of reach of children.
  • P261Avoid breathing dust/fume/gas/mist/vapours/spray.
  • P501Dispose of contents/container in accordance with local regulations.

Resistance management

Mode-of-action group, classified by the Fungicide Resistance Action Committee. Rotate products across different groups to slow resistance build-up.

Metconazole

3FRAC

Group 3

To manage resistance, avoid consecutive applications of growth-regulators from the same FRAC group. Alternate with products of a different mode of action within a programme.